<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04716270</url>
  </required_header>
  <id_info>
    <org_study_id>Version 1.0 of 2020-08-05</org_study_id>
    <nct_id>NCT04716270</nct_id>
  </id_info>
  <brief_title>Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure</brief_title>
  <acronym>AALARA</acronym>
  <official_title>Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure (AALARA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mohamed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study is to demonstrate a clinically significant reduction of ionizing&#xD;
      radiation exposure during transcatheter ablation of supraventricular tachycardias using the&#xD;
      EnSite precision mapping system in a real-world clinical setting without compromising&#xD;
      efficacy and safety.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2021</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Radiation exposure dose</measure>
    <time_frame>The day of performing the procedure</time_frame>
    <description>The dose of ionizing radiation exposure in patients undergoing Supraventricular Tachycardia catheter ablation utilizing a non-fluoroscopic EnSite Precision 3D mapping system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of procedure related cardiac Adverse Events (Safety)</measure>
    <time_frame>6 months</time_frame>
    <description>Cardiac related serious adverse events frequency during and after ablation procedure of supraventricular arrhythmias</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>The day of performing the procedure</time_frame>
    <description>Fluoroscopy time during the procedure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Tachycardia, Supraventricular</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrophysiology Study and Ablation</intervention_name>
    <description>Electrophysiology Study and Ablation of Supraventricular Arrhythmias</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female patients ≥ 18 years of age, indicated for supraventricular arrhythmias&#xD;
        ablation according to the current local applicable guidelines&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female patients ≥ 18 years of age&#xD;
&#xD;
          -  Patient indicated for supraventricular arrhythmias ablation according to the current&#xD;
             guidelines&#xD;
&#xD;
          -  Patient is willing to provide written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is pregnant.&#xD;
&#xD;
          -  Contraindications to ionizing radiation exposure&#xD;
&#xD;
          -  Patient's life expectancy is less than 1 year&#xD;
&#xD;
          -  Associated complex congenital heart disease&#xD;
&#xD;
          -  Cardiac implantable electric devices&#xD;
&#xD;
          -  Known pathological venous access to the heart&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Amin, MRCP(UK)FHRS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mohamed Bin Khalifa Cardiac Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MOHAMMAD AMIN</last_name>
    <phone>0097317767739</phone>
    <email>drmohdamin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mohamed Bin Khalifa Cardiac Center</name>
      <address>
        <city>Ar Rifā'</city>
        <country>Bahrain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MOHAMMAD AMIN</last_name>
      <phone>17767739</phone>
      <email>drmohdamin@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Bahrain</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 15, 2021</study_first_submitted>
  <study_first_submitted_qc>January 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Supraventricular tachycardia</keyword>
  <keyword>Radiation exposure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Supraventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

